| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |